Literature DB >> 22480800

Adipose tissue volume is decreased in recently diagnosed cancer patients with cachexia.

Thorhallur Agustsson1, Pal Wikrantz, Mikael Rydén, Torkel Brismar, Bengt Isaksson.   

Abstract

OBJECTIVE: Approximately 50% of patients with cancer develop cachexia. The aim of the present study was to determine if there were differences in the amount of visceral and subcutaneous adipose tissues at the time of the diagnosis among patients with cancer cachexia (CC), patients with cancer and a stable weight (WS), and patients with cancer and weight loss because of gastrointestinal obstruction (GO).
METHODS: Patients with recently diagnosed cancer were divided into the CC, WS, and GO groups. Body composition was determined by bioimpedance. Basal metabolic rate and energy expenditure were estimated by indirect calorimetry. Visceral and subcutaneous white adipose tissues (WATs) were quantified by the segmentation of a 10-mm-thick computed tomographic slice obtained through the central part of the third lumbar vertebra.
RESULTS: The body mass index and body fat were decreased in the CC and GO groups compared with the WS group, but there were no significant differences between the two weight-losing groups. Lean body mass, total body water, and energy expenditure were similar among the groups. The visceral WAT volume was decreased in the CC but not in the GO group compared with the WS group (P < 0.05). The subcutaneous WAT was decreased in the CC and GO groups compared with the WS group (P < 0.001).
CONCLUSION: The WAT was decreased in the CC and GO groups compared with the WS group. Furthermore, patients with CC exhibited a selective decrease in visceral WAT. This may be new information regarding the WAT distribution in CC.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22480800     DOI: 10.1016/j.nut.2011.11.026

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  16 in total

Review 1.  The impact of exercise training on adipose tissue remodelling in cancer cachexia.

Authors:  Rita Ferreira; Rita Nogueira-Ferreira; Rui Vitorino; Lúcio Lara Santos; Daniel Moreira-Gonçalves
Journal:  Porto Biomed J       Date:  2017-06-11

Review 2.  Evidence and mechanisms of fat depletion in cancer.

Authors:  Maryam Ebadi; Vera C Mazurak
Journal:  Nutrients       Date:  2014-11-19       Impact factor: 5.717

3.  Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study.

Authors:  Mónica Patricia Cala; María Teresa Agulló-Ortuño; Elena Prieto-García; Carolina González-Riano; Lucía Parrilla-Rubio; Coral Barbas; Carmen Vanesa Díaz-García; Antonia García; Cristina Pernaut; Jorge Adeva; María Carmen Riesco; Francisco Javier Rupérez; Jose Antonio Lopez-Martin
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-02-20       Impact factor: 12.910

4.  A synthetic free fatty acid-regulated transgene switch in mammalian cells and mice.

Authors:  Ying Liu; Ghislaine Charpin-El Hamri; Haifeng Ye; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2018-10-12       Impact factor: 16.971

Review 5.  The role of triglyceride lipases in cancer associated cachexia.

Authors:  Suman K Das; Gerald Hoefler
Journal:  Trends Mol Med       Date:  2013-03-14       Impact factor: 11.951

Review 6.  Cancer Cachexia and MicroRNAs.

Authors:  Rodolfo Gonzalez Camargo; Henrique Quintas Teixeira Ribeiro; Murilo Vieira Geraldo; Emídio Matos-Neto; Rodrigo Xavier Neves; Luiz Carlos Carnevali; Felipe Fedrizzi Donatto; Paulo S M Alcântara; José P Ottoch; Marília Seelaender
Journal:  Mediators Inflamm       Date:  2015-10-04       Impact factor: 4.711

Review 7.  Pharmacokinetics of drugs in cachectic patients: a systematic review.

Authors:  Katja Trobec; Mojca Kerec Kos; Stephan von Haehling; Jochen Springer; Stefan D Anker; Mitja Lainscak
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

Review 8.  Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia.

Authors:  Maryam Ebadi; Vera C Mazurak
Journal:  Mediators Inflamm       Date:  2015-10-05       Impact factor: 4.711

Review 9.  Role of Exosomal MicroRNAs and myomiRs in the Development of Cancer Cachexia-Associated Muscle Wasting.

Authors:  Rodolfo Marinho; Paulo S M Alcântara; José P Ottoch; Marilia Seelaender
Journal:  Front Nutr       Date:  2018-01-09

10.  Adipose depot gene expression and intelectin-1 in the metabolic response to cancer and cachexia.

Authors:  Janice Miller; Gillian Dreczkowski; Michael I Ramage; Stephen J Wigmore; Iain J Gallagher; Richard J E Skipworth
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-03-31       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.